Cerus reported $50.81M in Sales Revenues for its fiscal quarter ending in December of 2024.





Sales Change Date
Cerus USD 50.81M 4.79M Dec/2024
GRIFOLS EUR 1.7B 280M Mar/2026
Haemonetics USD 346M 7.03M Mar/2026
Neogen USD 211.2M 13.49M Dec/2025
OraSure Technologies USD 26.76M 322K Dec/2025
Plus Therapeutics USD 1.37M 30K Dec/2025
Quidel USD 620M 104M Mar/2026
Rockwell Medical USD 25.83M 3.15M Jun/2024
STAAR Surgical USD 93.5M 145.9M Mar/2026
Terumo JPY 300.32B 3.69B Mar/2026
Utah Medical Products USD 9.04M 955K Dec/2025